Main / EBHC Symposium / Speakers
EBHC Symposium

Invited speakers:
  1. Ainur Aiypkhanova, Kazakhstan
  2. Małgorzata Bała, Poland
  3. Antoni Dedeu Baraldés, Spain
  4. Neil Bertelsen, Germany
  5. Janusz Cieszyński, Poland
  6. Marcin Czech, Poland
  7. Dominik Dziurda, Poland
  8. Karen Facey, UK
  9. Brian Godman, UK
  10. Grzegorz Juszczyk, Poland
  11. Zbigniew Król, Poland
  12. Brygida Kwiatkowska, Poland
  13. Piotr Merks, Poland
  14. Aleksander Nawrat, Poland
  15. Wija Oortwijn, Netherlands
  16. Robert Plisko, Poland
  17. Michael E. Porter, USA
  18. Alric Rüther, Germany
  19. Andrzej Ryś, Poland
  20. Agnieszka Słowik, Poland
  21. Mitchell Sugarman, USA
  22. Andrzej Śliwczyński, Poland
  23. Roman Topór-Mądry, Poland
  24. Magdalena Władysiuk, Poland

About speakres

Małgorzata Bała
Małgorzata Bała M.D., Ph.D.
Head of the Systematic Reviews Unit-Polish Cochrane Branch and an assistant professor and the head of the Department of Hygiene and Dietetics (Jagiellonian University Medical College, Cracow, Poland). Since 2005 she has been carrying out EBM teaching to students of the Jagiellonian University’s Faculty of Medicine and the School of Medicine in English, as well as to students of the EuroPubHealth course. Since 2000 Dr Małgorzata Bała has been involved in Cochrane activities. She is an author and co-author of several Cochrane reviews.
Her research activities are focused on EBM, particularly on the systematic reviews assessing effectiveness of therapeutic interventions, as well as the methodological aspects of clinical trials and treatment guidelines. Dr. Małgorzata Bała has also co-authored the chapters at the referential Polish textbook on EBM, entitled „Podstawy EBM, czyli medycyny opartej na danych naukowych dla lekarzy i studentów medycyny” (Editors: Piotr Gajewski, Roman Jaeschke, Jan Brożek; Cracow, 2008).
Within Cochrane Collaboration she is the Director of Cochrane Poland and has been cooperating with several Group (Tobacco Addiction Groups, Renal, Hepatobiliary, Stroke, Vascular and Skin Group).
Marcin Czech
Marcin Czech
Vice-Minister of Health
He initiates, coordinates and supervises the tasks performed by the Department of Drug Policy and Pharmacy. He supervises the operations of the Administrator of the System for Monitoring of Consumer Accidents and actions of the National Medicines Institute (NIL) in Warsaw.
He is a professor at the Warsaw University of Technology, a graduate of the Faculty of Medicine at the Medical University in Warsaw. He has two medical specialisations: epidemiology and public health. Marcin Czech graduated from the Master of Business Administration (International MBA) programme in the Warsaw University of Technology Business School, Health Economics at the Faculty of Economic Sciences of the University of Warsaw, the Production Engineering Faculty of the Warsaw University of Technology in the scope of doctoral studies in management; he took part in foreign internships and training i.a. at the York University, University of Liverpool in Great Britain, McMaster University in Canada. He is a lecturer at the Warsaw University of Technology Business School, cooperates with the Management Faculty of the Warsaw University; for 9 years he was an assistant professor in the Department of Pharmacoeconomics at the Faculty of Pharmacy of the Medical University of Warsaw. He has been a Member of the Board of the Polish Pharmacoeconomic Society and in the past was President of that organisation and currently is its President-elect. He actively participates in the International Society for Pharmacoeconomics and Outcomes Research. He is a founding member and member of the bodies of the Polish Coordinated Care Society. He took part in the creation of HTA guidelines of the AOTMiT. He is the author of over 200 publications on management, health economics, pharmacoeconomics and quality of life for both foreign and Polish magazines. He was a thesis advisor for over 100 master’s and diploma thesis; he is a member of various working groups (i.a. at the Polish academy of Sciences), editorial boards and scientific boards of specialist magazines, he peer-reviews scientific works (i.a. as an expert to the National Science Centre), doctoral thesis and books and scientific articles. Marcin Czech participated in the implementation of scientific subsidies offered i.a. by the European Union. He has experience working in business and consulting, specialising in health economics and Real World Evidence. He was recognised with awards of the Rector of the Medical University of Warsaw, including a first-degree individual scientific award, an award of the Rector of the Warsaw University of Technology for his educational programme and the “Best and Brightest” award by PwC.
Dominik Dziurda
Dominik Dziurda
Director of the Healthcare Services Department at the Agency for Health Technology Assessment and and Tariff System (AOTMiT). He graduated from the Faculty of Pharmacy at Jagiellonian University Medical College (CMUJ) in Cracow (2002) and the post-graduate programme: MBA for Medical Personnel at the Kozminski University in Warsaw (2010). Doctoral Student at the Warsaw School of Economics (SGH).
His work experience includes teaching at universities on subjects related to pharmaceutical law, pharmacoeconomics and organisation of the healthcare system. He has also worked as reimbursement director in national and central structures in the pharmaceutical industry and as an analyst and specialist in projects regarding access to medical care and quality management. President of the technical unit in the Fair and Affordable Pricing project, implemented within the Visegrad Group, a member of the Executive Committee of the POINTer project dedicated to the system of quality indicators.
At the AOTMiT he is responsible for i.a. projects related to transformation of the guaranteed services system, with focus on medical rehabilitation, coordinated care and issues concerning clinical practice guidelines.
Brian Godman
Brian Godman
Brian works with the World Health Organization, governments, health authorities and health insurance companies across continents including Africa, Asia, Europe, Middle East, and South America to enhance prescribing efficiency within scarce resources. This includes potential ways to value and fund new medicines including those for cancer and orphan diseases incorporating suggested models to optimize their use post launch. This has resulted in multiple publications (over 150 listed in Pub Med since 2008) and presentations to address these key issues.
Zbigniew J. Król
Zbigniew J. Król MD, PhD
Undersecretary of State at the Ministry of Health
Former Deputy director of the Agency for Medical Technology Assessment and an adjunct professor at the Institute of Public Health of the Jagiellonian University. From 2009 to 2011 he was on the board of Pfizer Polska sp. Z oo. Then he was the director of the Drawski Specialist Center (2012-2013) and the Specialist Hospital. S. Żeromski SPZOZ in Cracow (2013-2016).
He is an honorary member of the College of Family Physicians in Poland. In his account he has, among others. Delegation of the Baltic Sea Task Force (later Northern Diamension) Experts Group for Primary Health Care and EQUIP - European quality workshop group. He was also an expert on the World Health Organization and the World Health Organization, as well as the project manager for the Data for Decision Makers project (Harvard-Jagiellonian Consortium for Health).
Robert Plisko
Robert Plisko
President of HTA Consulting since 2006, he is one of the founders of the company. Robert - master of economy by education (Cracow University of Economics), started his career in the Polish National Centre for Quality Assessment in Health Care. Robert is the author of many publications on HTA and health care and as advisor to the World Bank he participated in projects conducted in Serbia. Robert heads the Economic Analyses Department and carries out projects in Asia and Australia. Calm and common sense are Robert's second nature.
Mitchell Sugarman
Mitchell Sugarman
President and CEO at Anchor Bay Consulting. He was Vice President of Global Health Economics, Policy and Payment for Medtronic’s CardioVascular Division. In this role, he was responsible for ensuring that reimbursement is a consideration in every functional area from product conception, through research and development, clinical and regulatory affairs, product launch and marketing. Prior to joining Medtronic, Mr. Sugarman worked at Kaiser Permanente for 19 years initially as the Director of a clinical genetics department, and later as the Director of Medical Technology Assessment. This position involved tracking new drugs, devices and procedures as they moved from experimental to non-experimental, and determining whether they should be part of the medical armamentarium. Critical issues evaluated included safety, efficacy and cost-effectiveness.
Andrzej Śliwczyński
Andrzej Śliwczyński
Doctor of Health Sciences, a graduate of the University of Łódź, obtained his scientific title at The Medical University of Łódź. Deputy Director of The Department of Analyses and Strategy in The Central Office of the National Health Fund, lecturer at The Humanities and Economics Academy in Łódź. Between 1987 and 2005 he worked and held managerial positions in the State Pharmaceutical Supply Company "Cefarm". Since 2005 he has been working at the Central Office of the National Health Fund. In 2012 he obtained postgraduate diploma of Database Studies.
Currently, he deals with analysis of large data sets concerning actual clinical practice. Author and co-author of dozens of articles published in national and international journals in the field of medicine and economics, discussing medical data analyses, financing in the health care system, epidemiology, pharmacoeconomics.
Member of the Transparency Council of the Agency for Health Technology Assessment.
Roman Topór-Mądry
Roman Topór-Mądry
President of the Agency for Health Technology Assessment and Tariff System. Doctor, specialist in public health, epidemiologist. Regional consultant in public health for the Małopolskie voivodeship. Deputy Director of the Institute of Public Health of the Faculty of Health Sciences at the Jagiellonian University Medical College. Participant and coordinator of many research projects, he worked in advisory teams to, i.a. the Ministry of Health, scientific societies, local governments, the European Commission, the World Bank.
Magdalena Władysiuk
Magdalena Władysiuk
President of CEESTAHC Society, CEO of MedInvest Scanner, Vice President of HTA Consulting.In HTA Consulting, she is responsible for the strategic development of the company through research and services development, new product launch and marketing. Ms. Wladysiuk main and primary aim is to provide high quality information or data based on evidence based medicine or health technology assessment methodology not only in Poland but in Europe and Asia. Key role of her work is to improve patient outcomes through better healthcare decisions.
In CEESTAHC she was responsible for the establishing and providing wide connection platform for discussion for all stakeholders in health care system. CEESTAHC mission is to improve the quality of health care systems value with the use of evidence.
She graduatd Medical Academy in Lublin and MBA, economy in Kozminski Academy in Warsaw.
She was Member of HTAi Annual Meeting in 2006-2008
We recommend
EBHC Symposium
Register now
© Ceestahc.org   Wykonała: Agencja A.R.T.   Wyświetleń:13194, Data modyfikacji:2018-08-10